The first-in-class oral factor D inhibitor danicopan (Voydeya) has been approved for the management of extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH). EVH affects ...
EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Study results Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as ...
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill, shares promising results of ensifentrine in helping patients with insufficient chronic obstructive ...
Ellen DeGeneres is speaking out about her mental health after being kicked out of Hollywood for “being mean.” Ellen, 66, opened up about using therapy as a means to treat her obsessive-compulsive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results